Company: INDP
Filing Date: 2025-03-27
Form Type: DRS
Source: 0001641172-25-000975
Chunk: 29

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-27
Form: DRS
Chunk 29
---
 immediately prior to such fundamental transaction.

| 16 |

Common Warrants

The following summary of certain terms and provisions of the common warrants that are being offered hereby is not complete and is subject to, and qualified in its entirety by, the provisions of the common warrants, the form of which is filed as an exhibit to the registration statement of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions of the form of the common warrants for a complete description of the terms and conditions of the common warrants.

Duration, Exercise Price and Form. Each common warrant offered hereby will have an initial exercise price per share equal to $ . The common warrants will be exercisable on the Warrant Stockholder Approval Date, provided that if the Pricing Conditions are met, the common warrants will be immediately upon issuance. The common warrants and will expire on the anniversary of the Warrant Stockholder Approval Date, provided that if the Pricing Conditions are met, the common warrants will expire on the anniversary of the date of issuance. The exercise price and number of shares of common stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting our common stock and the exercise price. The common warrants will be issued separately from the common stock or pre-funded warrants, as applicable, and will be held separately immediately thereafter. A common warrant to purchase one share of our common stock will be issued for every share of common stock or pre-funded warrant purchased in this offering. The common warrants will be issued in certificated form only.

We intend to promptly,
and in no event later than after the consummation of this offering,
seek the Warrant Stockholder Approval for the issuance of shares of common stock issuable upon exercise of the common warrants but we
cannot assure you that the Warrant Stockholder Approval will be obtained, provided, however, that if and only if the Pricing Conditions
are met, then we will not seek Warrant Stockholder Approval. We have agreed with the investors in this offering that, if we do not obtain
stockholder approval for the issuance of the shares of common stock upon exercise of the common warrants at the first stockholder meeting
for such purpose after this offering, we will call a stockholder meeting every
thereafter until the earlier of the date we obtain such approval or the common warrants are no longer outstanding.

Exercisability. The common warrants will be exercisable, at the option of each holder, in whole or in part, by delivering